The carnitine transporter network: Interactions with drugs

Current Chemical Biology

Volumn 4, Issue 2, 2010, Pages 108-123

  Indiveri, Cesare ^a   Pochini, Lorena ^a   Oppedisano, Francesca ^a   Tonazzi, Annamaria ^b,c  

^a UNIVERSITY OF CALABRIA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

Carnitine; Drugs; Homeostasis; Transporter

Indexed keywords

ACYL COENZYME A; CARNITINE; CARRIER PROTEIN; OMEPRAZOLE; PROTEIN OCTN 1; PROTEIN OCTN 2; PROTEIN OCTN 3; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ABSORPTION; BINDING SITE; CELL MEMBRANE; ENDOPLASMIC RETICULUM; EUKARYOTIC CELL; EXCRETION; HOMEOSTASIS; HUMAN; MEMBRANE TRANSPORT; MITOCHONDRION; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; REVIEW;

EUKARYOTA; MAMMALIA;

EID: 77951544453     PISSN: 18723136     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231310791170748     Document Type: Review

References (146)

1. Ramsay RR, Gandour RD, van der Leij FR. Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta 2001; 1546: 21-43.
2. Reda E, D'Iddio S, Nicolai R, Benatti P, Calvani M. The carnitine system and body composition. Acta Diabetol 2003; 40: S106-13.
3. Foster DW. The role of the carnitine system in human metabolism. Ann N Y Acad Sci 2004; 1033: 1-16. (Pubitemid 39656734)
4. Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet 2006; 142C: 77-85.
5. Bieber LL. Carnitine. Annu Rev Biochem 1988; 57: 261-283
6. Vaz FM, Wanders RJ. Carnitine biosynthesis in mammals. Biochem J 2002; 361: 417-429
7. Stephens FB, Constantin-Teodosiu D, Greenhaff PL. New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol 2007; 581: 431-444
8. Bremer J. Carnitine--metabolism and functions. Physiol Rev 1983; 63: 1420-1480
9. Indiveri C, Tonazzi A, Palmieri F. Identification and purification of the carnitine carrier from rat liver mitochondria. Biochim Biophys Acta 1990; 1020: 81-86 (Pubitemid 20350254)
10. Peluso G, Nicolai R, Reda E, Benatti P, Barbarisi A, Calvani M. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Physiol 2000; 182: 339-350 (Pubitemid 30054367)
11. Westin MA, Hunt MC, Alexson SE. Short- and medium-chain carnitine acyltransferases and acyl-CoA thioesterases in mouse provide complementary systems for transport of beta-oxidation products out of peroxisomes. Cell Mol Life Sci 2008; 65: 982-990
12. Gooding JM, Shayeghi M, Saggerson ED. Membrane transport of fatty acylcarnitine and free L-carnitine by rat liver microsomes. Eur J Biochem 2004; 271: 954-961
13. Tonazzi A, Galluccio M, Oppedisano F, Indiveri C. Functional reconstitution into liposomes and characterization of the carnitine transporter from rat liver microsomes. Biochim Biophys Acta 2006; 1758: 124-131
14. Indiveri C, Tonazzi A, Palmieri F. Characterization of the unidirectional transport of carnitine catalyzed by the reconstituted carnitine carrier from rat liver mitochondria. Biochim Biophys Acta 1991; 1069: 110-116
15. Indiveri C, Tonazzi A, Prezioso G, Palmieri F. Kinetic characterization of the reconstituted carnitine carrier from rat liver mitochondria. Biochim Biophys Acta 1991; 1065: 231-238
16. Eaton S. Control of mitochondrial beta-oxidation flux. Prog Lipid Res 2002; 41: 197-239.
17. Brass EP. Pivalate-generating prodrugs and carnitine homeostasis in man. Pharmacol Rev 2002; 54: 589-598
18. Pochini L, Oppedisano F, Indiveri C. Reconstitution into liposomes and functional characterization of the carnitine transporter from renal cell plasma membrane. Biochim Biophys Acta 2004; 1661: 78-86. (Pubitemid 38201573)
19. Ohnishi S, Okamura N, Sakamoto S, et al. Role of Na+/L-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment. Drug Metab Pharmacokinet 2008; 23: 293-303.
20. Tamai I, Ohashi R, Nezu J, et al. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 2000; 275: 40064-40072 (Pubitemid 32064631)
21. Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci 2004; 1033: 30-41. (Pubitemid 39656736)
22. Huizing M, Iacobazzi V, Ijlst L, et al. Cloning of the human carnitine-acylcarnitine carrier cDNA and identification of the molecular defect in a patient. Am J Hum Genet 1997; 61: 1239-1245 (Pubitemid 28046898)
23. Lahjouji K, Mitchell GA, Qureshi IA. Carnitine transport by organic cation transporters and systemic carnitine deficiency. Mol Genet Metab 2001; 73: 287-297 (Pubitemid 32846367)
24. Palmieri F. Diseases caused by defects of mitochondrial carriers: a review. Biochim Biophys Acta 2008; 1777: 564-578
25. Kido Y, Tamai I, Ohnari A, et al. Functional relevance of carnitine transporter OCTN2 to brain distribution of L-carnitine and acetyl-L-carnitine across the blood-brain barrier. J Neurochem 2001; 79: 959-969 (Pubitemid 33117074)
26. Ohnishi S, Saito H, Fukada A, Inui KI. Independent organic cation transport activity of Na(+)-L-carnitine cotransport system in LLCPK(1) cells. Am J Physiol Renal Physiol 2001; 281: F273-9.
27. Elimrani I, Lahjouji K, Seidman E, Roy MJ, Mitchell GA, Qureshi I. Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells. Am J Physiol Gastrointest Liver Physiol 2003; 284: G863-71. (Pubitemid 36437987)
28. Xuan W, Lamhonwah AM, Librach C, Jarvi K, Tein I. Characterization of organic cation/carnitine transporter family in human sperm. Biochem Biophys Res Commun 2003; 306: 121-128 (Pubitemid 36629414)
29. Duran JM, Peral MJ, Calonge ML, Ilundain AA. OCTN3: A Na+-independent L-carnitine transporter in enterocytes basolateral membrane. J Cell Physiol 2005; 202: 929-935
30. Rytting E, Audus KL. Novel organic cation transporter 2-mediated carnitine uptake in placental choriocarcinoma (BeWo) cells. J Pharmacol Exp Ther 2005; 312: 192-198 (Pubitemid 40096468)
31. Hirano T, Yasuda S, Osaka Y, Kobayashi M, Itagaki S, Iseki K. Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells. Biochim Biophys Acta 2006; 1758: 1743-1750 (Pubitemid 44666678)
32. Kato Y, Sugiura M, Sugiura T, et al. Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse. Mol Pharmacol 2006; 70: 829-837 (Pubitemid 44268440)
33. Kwok B, Yamauchi A, Rajesan R, et al. Carnitine/xenobiotics transporters in the human mammary gland epithelia, MCF12A. Am J Physiol Regul Integr Comp Physiol 2006; 290: R793-802.
34. Inazu M, Takeda H, Maehara K, Miyashita K, Tomoda A, Matsumiya T. Functional expression of the organic cation/carnitine transporter 2 in rat astrocytes. J Neurochem 2006; 97: 424-434 (Pubitemid 36182074)
35. Okamura N, Ohnishi S, Shimaoka H, Norikura R, Hasegawa H. Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by pivalic acid and valproic acid. Pharm Res 2006; 23: 1729-1735 (Pubitemid 44200535)
36. Glube N, Closs E, Langguth P. OCTN2-mediated carnitine uptake in a newly discovered human proximal tubule cell line (Caki-1). Mol Pharm 2007; 4: 160-168 (Pubitemid 46302138)
37. Kobayashi D, Tamai I, Sai Y, et al. Transport of carnitine and acetylcarnitine by carnitine/organic cation transporter (OCTN) 2 and OCTN3 into epididymal spermatozoa. Reproduction 2007; 134: 651-658 (Pubitemid 350143148)
38. Rytting E, Audus KL. Effects of low oxygen levels on the expression and function of transporter OCTN2 in BeWo cells. J Pharm Pharmacol 2007; 59: 1095-1102 (Pubitemid 47265356)
39. Garrett Q, Xu S, Simmons PA, Vehige J, Flanagan JL, Willcox MD. Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium. Invest Ophthalmol Vis Sci 2008; 49: 4844-4849
40. Iwata D, Kato Y, Wakayama T, et al. Involvement of carnitine/ organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart. Drug Metab Pharmacokinet 2008; 23: 207-215
41. Huang FD, Kung FL, Tseng YC, Chen MR, Chan HS, Lin CJ. Regulation of protein expression and function of octn2 in forskolininduced syncytialization in BeWo Cells. Placenta 2009; 30: 187-194
42. Tamai I, Yabuuchi H, Nezu J, et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 1997; 419: 107-111 (Pubitemid 28011227)
43. Tamai I, Ohashi R, Nezu J, et al. Molecular and functional identification of sodium iondependent, high affinity human carnitine transporter OCTN2. J Biol Chem 1998; 273: 20378-20382 (Pubitemid 28377603)
44. Wu X, Prasad PD, Leibach FH, Ganapathy V. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 1998; 246: 589-595
45. Ohashi R, Tamai I, Yabuuchi H, et al. Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 1999; 291: 778-784 (Pubitemid 29503553)
46. Seth P, Wu X, Huang W, Leibach FH, Ganapathy V. Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function. J Biol Chem 1999; 274: 33388-33392 (Pubitemid 129511642)
47. Yabuuchi H, Tamai I, Nezu J, et al. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 1999; 289: 768-773 (Pubitemid 29191230)
48. Wu X, Huang W, Prasad PD, et al. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 1999; 290: 1482-1492 (Pubitemid 29400294)
49. Wagner CA, Lükewille U, Kaltenbach S, et al. Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2. Am J Physiol Renal Physiol 2000; 279: F584-91.
50. Wang Y, Taroni F, Garavaglia B, Longo N. Functional analysis of mutations in the OCTN2 transporter causing primary carnitine deficiency: lack of genotype-phenotype correlation. Hum Mutat 2000; 16: 401-407
51. Wu X, George RL, Huang W, et al. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim Biophys Acta 2000; 1466: 315-327 (Pubitemid 30312986)
52. Ohashi R, Tamai I, Nezu JI, et al. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol Pharmacol 2001; 59: 358-366 (Pubitemid 32108570)
53. Ohashi R, Tamai I, Inano A, et al. Studies on functional sites of organic cation/carnitine transporter OCTN2 (SLC22A5) using a Ser 467Cys mutant protein. J Pharmacol Exp Ther 2002; 302: 1286-1294 (Pubitemid 34920254)
54. Lamhonwah AM, Skaug J, Scherer SW, Tein I. A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn's disease locus (IBD5). Biochem Biophys Res Commun 2003; 301: 98-101.
55. Tamai I, Nakanishi T, Kobayashi D, et al. Involvment of OCTN1 (SLC22A4) in pH-dependent transport of organic cation. Mol Pharm 2004; 1: 57-66.
56. Grundemann D, Harlfinger S, Golz S, et al. Discovery of the ergothioneine transporter. Proc Natl Acad Sci USA 2005; 102: 5256-5261
57. Kato Y, Sai Y, Yoshida K, Watanabe C, Hirata T, Tsuji A. PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2. Mol Pharmacol 2005; 67: 734-743 (Pubitemid 40365320)
58. Lamhonwah AM, Tein I. Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. Biochem Biophys Res Commun 2006; 345: 1315-1325 (Pubitemid 43833440)
59. Nagai K, Takikawa O, Kawakami N, et al. Cloning and functional characterization of a novel up-regulator, cartregulin, of carnitine transporter, OCTN2. Arch Biochem Biophys 2006; 452: 29-37. (Pubitemid 44107337)
60. Todesco L, Bur D, Brooks H, et al. Pharmacological manipulation of L-carnitine transport into L6 cells with stable overexpression of human OCTN2. Cell Mol Life Sci 2008; 65: 1596-1608.
61. Grigat S, Harlfinger S, Pal S, et al. Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations. Biochem Pharmacol 2007; 74: 309-316 (Pubitemid 46890822)
62. Nakamura T, Yoshida K, Yabuuchi H, Maeda T, Tamai I. Functional characterization of ergothioneine transport by rat organic cation/carnitine transporter Octn1 (slc22a4). Biol Pharm Bull 2008; 31: 1580-1584
63. Urban TJ, Brown C, Castro RA, et al. Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin. Clin Pharmacol Ther 2008; 83: 416-421 (Pubitemid 351272627)
64. Ohnishi S, Saito H, Fukada A, Inui K. Distinct transport activity of tetraethylammonium from L-carnitine in rat renal brush-border membranes. Biochim Biophys Acta 2003; 1609: 218-224 (Pubitemid 36120730)
65. Pande SV, Murthy MS. Carnitine-acylcarnitine translocase deficiency: implications in human pathology. Biochim Biophys Acta 1994; 1226: 269-276
66. Indiveri C, Iacobazzi V, Giangregorio N, Palmieri F. Bacterial overexpression, purification, and reconstitution of the carnitine/ acylcarnitine carrier from rat liver mitochondria. Biochem Biophys Res Commun 1998; 249: 589-594 (Pubitemid 28441882)
67. Oppedisano F, Fanello D, Calvani M, Indiveri C. Interaction of mildronate with the mitochondrial carnitine/acylcarnitine transport protein. J Biochem Mol Toxicol 2008; 22: 8-14. (Pubitemid 351360157)
68. Pochini L, Galluccio M, Scumaci D, et al. Interaction of betalactam antibiotics with the mitochondrial carnitine/acylcarnitine transporter. Chem Biol Interact 2008; 173: 187-194
69. Pochini L, Scalise M, Indiveri C. Inactivation by omeprazole of the carnitine transporter (OCTN2) reconstituted in liposomes. Chem Biol Interact 2009; 179: 394-401.
70. Brass EP, Mayer MD, Mulford DJ, Stickler TK, Hoppel CL. Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil. Clin Pharmacol Ther 2003; 73: 338-347
71. Brass EP. Carnitine and sports medicine: use or abuse? Ann N Y Acad Sci 2004; 1033: 67-78.
72. Krahenbuhl S, Brass EP. Fuel homeostasis and carnitine metabolism in rats with secondary biliary cirrhosis. Hepatology 1991; 14: 927-934
73. Krahenbuhl S, Willer B, Bruhlmann P, Hoppeler H, Stucki G. Carnitine homeostasis in patients with rheumatoid arthritis. Clin Chim Acta 1999; 279: 35-45. (Pubitemid 29067377)
74. Makowski L, Noland RC, Koves TR, et al. Metabolic profiling of PPARalpha-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. FASEB J 2009; 23: 586-604.
75. Stephens FB, Constantin-Teodosiu D, Laithwaite D, Simpson EJ, Greenhaff PL. Insulin stimulates L-carnitine accumulation in human skeletal muscle. FASEB J 2006; 20: 377-379 (Pubitemid 46671177)
76. Calvani M, Reda E, Arrigoni-Martelli E. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions. Basic Res Cardiol 2000; 95: 75-83. (Pubitemid 30251262)
77. Simkhovich BZ, Shutenko ZV, Meirena DV, et al. 3-(2,2,2- Trimethylhydrazinium) propionate (THP) - a novel gammabutyrobetaine hydroxylase inhibitor with cardioprotective properties. Biochem Pharmacol 1988; 37: 195-202.
78. Dambrova M, Liepinsh E, Kalvinsh I. Mildronate: cardioprotective action through carnitine-lowering effect. Trends Cardiovasc Med 2002; 12: 275-279 (Pubitemid 35286766)
79. Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 2009; 121: 29-40.
80. Indiveri C, Tonazzi A, Palmieri F. The reconstituted carnitine carrier from rat liver mitochondria: evidence for a transport mechanism different from that of the other mitochondrial translocators. Biochim Biophys Acta 1994; 1189: 65-73. (Pubitemid 24029714)
81. Idell-Wenger JA, Grotyohann LW, Neely JR. Coenzyme A and carnitine distribution in normal and ischemic hearts. J Biol Chem 1978; 253: 4310-4318 (Pubitemid 8380658)
82. Engel AG, Rebouche CJ, Wilson DM, Glasgow AM, Romshe CA, Cruse RP. Primary systemic carnitine deficiency. II. Renal handling of carnitine. Neurology 1981; 31: 819-825
83. Karlic H, Lohninger A. Supplementation of L-carnitine in athletes: does it make sense? Nutrition 2004; 20: 709-715
84. Wang Y, Meadows TA, Longo N. Abnormal sodium stimulation of carnitine transport in primary carnitine deficiency. J Biol Chem 2000; 275: 20782-20786 (Pubitemid 30457669)
85. Tamai I, China K, Sai Y, et al. Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. Biochim Biophys Acta 2001; 1512: 273-284
86. Lee AG. Lipid-protein interactions in biological membranes: a structural perspective. Biochim Biophys Acta 2003; 1612: 1-40. (Pubitemid 36555684)
87. Maekawa S, Mori D, Nishiya T, et al. OCTN2VT, a splice variant of OCTN2, does not transport carnitine because of the retention in the endoplasmic reticulum caused by insertion of 24 amino acids in the first extracellular loop of OCTN2. Biochim Biophys Acta 2007; 1773: 1000-1006 (Pubitemid 46829451)
88. Tahara H, Yee SW, Urban TJ, et al. Functional Genetic Variation in the Basal Promoter of the Organic Cation/Carnitine Transporters, OCTN1 (SLC22A4) and OCTN2 (SLC22A5). J Pharmacol Exp Ther 2009; In press.
89. Lamhonwah AM, Ackerley CA, Tilups A, Edwards VD, Wanders RJ, Tein I. OCTN3 is a mammalian peroxisomal membrane carnitine transporter. Biochem Biophys Res Commun 2005; 338: 1966-1972 (Pubitemid 41643114)
90. Alnouti Y, Petrick JS, Klaassen CD. Tissue distribution and ontogeny of organic cation transporters in mice. Drug Metab Dispos 2006; 34: 477-482 (Pubitemid 43290907)
91. Lamhonwah AM, Hawkins CE, Tam C, Wong J, Mai L, Tein I. Expression patterns of the organic cation/carnitine transporter family in adult murine brain. Brain Dev 2008; 30: 31-42. (Pubitemid 350296742)
92. Enomoto A, Wempe MF, Tsuchida H, et al. Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J Biol Chem 2002; 277: 36262-36271
93. Jeulin C, Lewin LM. Role of free L-carnitine and acetyl-L-carnitine in post-gonadal maturation of mammalian spermatozoa. Hum Reprod Update 1996; 2: 87-102. (Pubitemid 26173037)
94. Nakanishi T, Hatanaka T, Huang W, et al. Na+- and Cl - coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes. J Physiol 2001; 532: 297-304.
95. Srinivas SR, Prasad PD, Umapathy NS, Ganapathy V, Shekhawat PS. Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+). Am J Physiol Gastrointest Liver Physiol 2007; 293: G1046-53. (Pubitemid 350106559)
96. Luci S, Geissler S, Konig B, et al. PPARalpha agonists up-regulate organic cation transporters in rat liver cells. Biochem Biophys Res Commun 2006; 350: 704-708 (Pubitemid 44547904)
97. Maeda T, Wakasawa T, Funabashi M, et al. Regulation of Octn2 transporter (SLC22A5) by peroxisome proliferator activated receptor alpha. Biol Pharm Bull 2008; 31: 1230-1236 (Pubitemid 351871185)
98. Ringseis R, Wege N, Wen G, et al. Carnitine synthesis and uptake into cells are stimulated by fasting in pigs as a model of nonproliferating species. J Nutr Biochem 2008; In press.
99. Palmieri F. The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch 2004; 447: 689-709. (Pubitemid 38241455)
100. Weibel ER, Staubli W, Gnagi HR, Hess FA. Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereologic methods, and normal morphometric data for rat liver. J Cell Biol 1969; 42: 68-91.
101. Hammel I, Shor-Hazan O, Eldar T, Amihai D, Lew S. Morphometric studies of secretory granule formation in mouse pancreatic acinar cells. Dissecting the early structural changes following pilocarpine injection. J Anat 1999; 194: 51-60. (Pubitemid 29126694)
102. Palade GE. The endoplasmic reticulum. J Biophys Biochem Cytol 1956; 2: 85-98.
103. Benedetti A, Banhegyi G, Burchell A. Endoplasmic Reticulum: A Metabolic Compartment. Amsterdam, IOS Press, 2005.
104. Rapoport TA, Jungnickel B, Kutay U. Protein transport across the eukaryotic endoplasmic reticulum and bacterial inner membranes. Annu Rev Biochem 1996; 65: 271-303. (Pubitemid 26250611)
105. Gibbons GF, Bartlett SM, Sparks CE, Sparks JD. Extracellular fatty acids are not utilized directly for the synthesis of very-low-density lipoprotein in primary cultures of rat hepatocytes. Biochem J 1992; 287: 749-753
106. Yang LY, Kuksis A, Myher JJ, Steiner G. Origin of triacylglycerol moiety of plasma very low density lipoproteins in the rat: structural studies. J Lipid Res 1995; 36: 125-136
107. Broadway NM, Gooding JM, Saggerson ED. Carnitine acyltransferases and associated transport processes in the endoplasmic reticulum. Missing links in the VLDL story? Adv Exp Medical Biol 1999; 466: 59-67.
108. Gibbons GF, Islam K, Pease RJ. Mobilisation of triacylglycerol stores. Biochim Biophys Acta 2000; 1483: 37-57.
109. Joyce C, Skinner K, Anderson RA, Rudel LL. AcylcoenzymeA: cholesteryl acyltransferase 2. Curr Opin Lipidol 1999; 10: 89-95.
110. Buhman KF, Accad M, Farese RV. Mammalian acyl-CoA: cholesterol acyltransferases. Biochim Biophys Acta 2000; 1529: 142-154
111. Joyce CW, Shelness GS, Davis MA, et al. ACAT1 and ACAT2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane. Mol Biol Cell 2000; 11: 3675-3687
112. Rudel LL, Lee RG, Cockman TL. Acyl coenzymeA: cholesterol acyltransferase types 1 and 2 structure and function in atherosclerosis. Curr Opin Lipidol 2001; 12: 121-127
113. Polokoff MA, Bell RM. Limited palmitoyl-CoA penetration into microsomal vesicles as evidenced by a highly latent ethanol acyltransferase activity. J Biol Chem 1978; 253: 7173-7178
114. Murthy MS, Pande SV. Malonyl-CoA-sensitive and -insensitive carnitine palmitoyltransferase activities of microsomes are due to different proteins. J Biol Chem 1994; 269: 18283-18286
115. Broadway NM, Saggerson ED. Solubilization and separation of two distinct carnitine acyltransferases from hepatic microsomes: characterization of the malonyl-CoA-sensitive enzyme. Biochem J 1995; 310: 989-995
116. van Iwaarden PR, Driessen AJ, Konings WN. What we can learn from the effects of thiol reagents on transport proteins. Biochim Biophys Acta 1992; 1113: 161-170
117. Tonazzi A, Giangregorio N, Indiveri C, Palmieri F. Identification by site-directed mutagenesis and chemical modification of three vicinal cysteine residues in rat mitochondrial carnitine/acylcarnitine transporter. J Biol Chem 2005; 280: 19607-19612 (Pubitemid 41379483)
118. 3H] ethane-2,2′-disulfonic acid. J Biol Chem 1982; 257: 3919-3924
119. Guillen E, Hirschberg CB. Transport of adenosine triphosphate into endoplasmic reticulum proteoliposomes. Biochemistry 1995; 34: 5472-5476
120. Rush JS, Waechter CJ. Functional reconstitution into proteoliposomes and partial purification of a rat liver ER transport system for a water soluble analogue of mannosylphosphoryldolichol. Biochemistry 2004; 43: 7643-7652
121. Ramsay RR. Carnitine and its role in acyl group metabolism. Essays Biochem 1994; 28: 47-61.
122. Wanders RJ, Vreken P, Ferdinandusse S, et al. Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases. Biochem Soc Trans 2001; 29: 250-267 (Pubitemid 32587514)
123. Ramsay R R. The soluble carnitine palmitoyltransferase from bovine liver. Biochem J 1988; 249: 239-245
124. Derrick JP, Ramsay R. R. L-Carnitine acyltransferase in intact peroxisomes is inhibited by malonyl-CoA. Biochem J 1989; 262: 801-806
125. Jakobs BS, Wanders RJ. Fatty acid beta-oxidation in peroxisomes and mitochondria: the first, unequivocal evidence for the involvement of carnitine in shuttling propionyl-CoA from peroxisomes to mitochondria. Biochem Biophys Res Commun 1995; 213: 1035-1041
126. Visser WF, van Roermund CW, Ijlst L, Waterham HR, Wanders RJ. Metabolite transport across the peroxisomal membrane. Biochem J 2007; 401: 365-375 (Pubitemid 46166420)
127. Hettema EH, van Roermund CWT, Distel B, et al. The ABC transporter proteins Pat1 and Pat2 are required for import of long-chain fatty acids into peroxisomes of Saccharomyces cerevisiae. EMBO J 1996; 15: 3813-3822 (Pubitemid 26289791)
128. Tune BM, Hsu CY. Toxicity of cephaloridine to carnitine transport and fatty acid metabolism in rabbit renal cortical mitochondria: structure-activity relationships. J Pharmacol Exp Ther 1994; 270: 873-880
129. Ganapathy ME, Huang W, Rajan DP, et al. beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter. J Biol Chem 2000; 275: 1699-1707 (Pubitemid 30060789)
130. Watanabe K, Sawano T, Endo T, Sakata M, Sato J. Studies on intestinal absorption of sulpiride (2): transepithelial transport of sulpiride across the human intestinal cell line Caco-2. Biol Pharm Bull 2002; 25: 1345-1350
131. Georges B, Galland S, Rigault C, Le Borgne F, Demarquoy J. Beneficial effects of L-carnitine in myoblastic C2C12 cells. Interaction with zidovudine. Biochem Pharmacol 2003; 65: 1483-1488
132. Grube M, Meyer zu Schwabedissen HE, Prager D, et al. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation 2006; 113: 1114-1122 (Pubitemid 43754279)
133. Hu S, Franke RM, Filipski KK, et al. Interaction of imatinib with human organic ion carriers. Clin Cancer Res 2008; 14: 3141-3148
134. Grigat S, Fork C, Bach M, et al. The carnitine transporter SLC22A5 is not a general drug transporter, but it efficiently translocates mildronate. Drug Metab Dispos 2009; 37: 330-337
135. Kano T, Kato Y, Ito K, Ogihara T, Kubo Y, Tsuji A. Carnitine/ organic cation transporter OCTN2 (Slc22a5) is responsible for renal secretion of cephaloridine in mice. Drug Metab Dispos 2009; In press.
136. Spaniol M, Kaufmann P, Beier K, et al. Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate. J Lipid Res 2003; 44: 144-153 (Pubitemid 36114780)
137. Zaugg CE, Spaniol M, Kaufmann P, et al. Myocardial function and energy metabolism in carnitine-deficient rats. Cell Mol Life Sci 2003; 60: 767-775 (Pubitemid 36570767)
138. Indiveri C, Giangregorio N, Iacobazzi V, Palmieri F. Site-directed mutagenesis and chemical modification of the six native cysteine residues of the rat mitochondrial carnitine carrier: implications for the role of cysteine-136. Biochemistry 2002; 41: 8649-8656 (Pubitemid 34743304)
139. Tune BM, Hsu CY. Toxicity of cephalosporins to fatty acid metabolism in rabbit renal cortical mitochondria. Biochem Pharmacol 1995; 49: 727-734
140. Tune BM. Nephrotoxicity of beta-lactam antibiotics: mechanisms and strategies for prevention. Pediatr Nephrol 1997; 11: 768-772 (Pubitemid 27520549)
141. Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 2007; 24: 1227-1251 (Pubitemid 46876495)
142. Fourtillan JB, Leroy A, Lefebvre MA, et al. Cross-over study of the pharmacokinetics of cefonicid administered intravenously or intramuscularly to healthy adult humans. Eur J Drug Metab Pharmacokinet 1985; 10: 225-230 (Pubitemid 16198376)
143. McGarry JD, Foster DW. Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem 1980; 49: 395-420.
144. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schönekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994; 1213: 263-276 (Pubitemid 24262910)
145. Bartlett K, Eaton S. Mitochondrial beta-oxidation. Eur J Biochem 2004; 271: 462-469
146. Kalman D, Barriere SL. Review of the pharmacology, pharmacokinetics, and clinical use of cephalosporins. Tex Heart Inst J 1990; 17: 203-215